What are the key differences between a fibroma and a lipoma regarding composition, clinical presentation, and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fibroma vs Lipoma: Key Differences

A lipoma is a benign tumor composed of mature adipose tissue that appears as a soft, mobile, subcutaneous mass, while a fibroma is a benign tumor composed of fibrous connective tissue that typically presents as a firmer, less mobile mass.

Composition

  • Lipoma: Composed entirely of mature fat cells (adipocytes) encapsulated within a thin fibrous capsule
  • Fibroma: Composed of fibrous connective tissue with collagen and fibroblasts, lacking adipose tissue

Clinical Presentation

Lipoma Characteristics:

  • Texture: Soft, doughy, compressible
  • Mobility: Highly mobile under the skin, slips easily under palpation
  • Location: Most commonly subcutaneous (superficial to deep fascia)
  • Size: Variable, can range from small (1-2 cm) to large (>10 cm)
  • Growth: Slow-growing, typically asymptomatic
  • Note: Physical examination alone correctly identifies only 85% of lipomas 1

Fibroma Characteristics:

  • Texture: Firm, rubbery, non-compressible
  • Mobility: Less mobile, more fixed to surrounding tissue
  • Location: Can be superficial or deep
  • Size: Usually smaller than lipomas
  • Growth: Slow-growing, may cause discomfort if pressing on nerves

Diagnostic Approach

For Superficial Masses:

Start with plain radiographs as the initial imaging modality for any suspected soft-tissue mass 1. Radiographs demonstrate positive findings in 62% of cases, identifying intrinsic fat in 11% of cases 1.

Follow with ultrasound for superficial lesions:

  • Lipoma on US: Shows characteristic features including no or minimal acoustic shadowing, no or minimal vascularity, and simple curved echogenic lines within an encapsulated mass 1
  • US has 94.1% sensitivity and 99.7% specificity for superficial soft-tissue masses, with highest accuracy for lipomas 1
  • Critical caveat: If US or clinical features are atypical, further imaging with MRI is required 1

For Deep or Nonspecific Masses:

  • Radiographs remain first-line but may be unrewarding for deep-seated, non-mineralized masses 1
  • US diagnostic accuracy is considerably less for lesions outside subcutaneous tissue 1
  • MRI becomes necessary for definitive characterization of deep masses

Management Differences

Lipoma:

  • Observation is appropriate for asymptomatic, confirmed lipomas
  • Excision indicated if: symptomatic, cosmetically concerning, rapidly growing, or diagnostic uncertainty
  • Simple excision is curative

Fibroma:

  • Excision is typically recommended for definitive diagnosis and treatment
  • Complete excision prevents recurrence
  • Histopathologic confirmation is important to exclude other fibrous lesions

Critical Pitfalls to Avoid

  1. Do not rely on physical examination alone - only 85% accurate for lipomas 1
  2. Do not skip radiographs - they provide essential baseline information and may reveal unexpected findings
  3. Do not assume all soft subcutaneous masses are lipomas - atypical features on US mandate further imaging
  4. Do not use MRI as initial imaging - it has inherent limitations in identifying mineralization and is not supported as first-line 1

References

Guideline

acr appropriateness criteria<sup>®</sup> soft-tissue masses.

Journal of the American College of Radiology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.